ImmunoQure

ImmunoQure AG is a young biotechnology company responsible for researching and developing human-derived autoantibodies for the treatment of human diseases. Through our unique access to rare patient populations, we are able to link clinical conditions with serological characteristics and subsequently clone autoantibodies optimized to target key drug targets for the prevention of various human diseases.